{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:55:10Z","timestamp":1764791710234,"version":"3.46.0"},"reference-count":36,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,1]]},"abstract":"<jats:sec>\n                    <jats:title>Context.\u2014<\/jats:title>\n                    <jats:p>Serology plays a vital role in celiac disease (CD) diagnosis, and the latest European guidelines advocate for biopsy-free diagnoses in patients with \u226510\u00d7 the upper limit of normal (ULN) of anti\u2013tissue transglutaminase (tTG) immunoglobulin A (IgA) antibodies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective.\u2014<\/jats:title>\n                    <jats:p>To assess performance characteristics of a novel automated particle-based multianalyte technology (Aptiva) for anti-tTG and anti\u2013deamidated gliadin peptide (DGP) antibody detection as compared to the traditional enzyme-linked immunosorbent assay (QUANTA Lite). Performance characteristics of the \u226510\u00d7 ULN anti\u2013tTG IgA criteria for serologic diagnosis of CD were also evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design.\u2014<\/jats:title>\n                    <jats:p>Sera samples from 703 patients were tested for anti\u2013tTG IgA, anti\u2013tTG immunoglobulin G (IgG), anti\u2013DGP IgA, and anti\u2013DGP IgG antibodies on both platforms. In total, 127 patients had medical information and were classified as CD-positive (n\u2009=\u200958) and CD-negative (n\u2009=\u200969) based on biopsy results. Clinical performance characteristics were evaluated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results.\u2014<\/jats:title>\n                    <jats:p>Anti\u2013tTG IgA detection showed equal clinical sensitivity and specificity of 91% sensitivity and 99% specificity on both platforms. Anti\u2013tTG IgG resulted in moderate sensitivity of 69% and 72%, but high specificity of 100% and 94% on Aptiva and QUANTA Lite, respectively. Anti\u2013DGP IgG displayed comparable sensitivity of 90% and 81%, and a specificity of 94% and 99%, on Aptiva and QUANTA Lite, respectively. Anti\u2013DGP IgA demonstrated greater sensitivity on QUANTA Lite (83%) than Aptiva (69%) and similar specificities of 97% and 98% on QUANTA Lite and Aptiva, respectively. At \u226510\u00d7 ULN levels for anti\u2013tTG IgA, Aptiva displayed a sensitivity of 72% and a specificity of 100%, and QUANTA Lite showed a sensitivity of 69% and a specificity of 100%.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions.\u2014<\/jats:title>\n                    <jats:p>Aptiva is a reliable method to measure CD biomarkers with reduced hands-on necessity and high-throughput capabilities. This study supports the use of a \u226510\u00d7 ULN anti\u2013tTG IgA biopsy-free approach for serologic diagnosis of CD.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.5858\/arpa.2022-0385-oa","type":"journal-article","created":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T10:26:53Z","timestamp":1677666413000},"page":"1422-1430","source":"Crossref","is-referenced-by-count":4,"title":["Performance Assessment of a Novel Multianalyte Methodology for Celiac Disease Biomarker Detection and Evaluation of the Serology-Alone Criteria for Biopsy-Free Diagnosis"],"prefix":"10.5858","volume":"147","author":[{"given":"Camille Leite","family":"Novis","sequence":"first","affiliation":[{"name":"From the ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah (Novis, Nandakumar)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward","family":"Wahl","sequence":"additional","affiliation":[{"name":"Research and Development, Headquarters and Technology Center Autoimmunity, Werfen, San Diego, California (Wahl, Camacho, Aure, Mahler)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric","family":"Camacho","sequence":"additional","affiliation":[{"name":"Research and Development, Headquarters and Technology Center Autoimmunity, Werfen, San Diego, California (Wahl, Camacho, Aure, Mahler)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Ann","family":"Aure","sequence":"additional","affiliation":[{"name":"Research and Development, Headquarters and Technology Center Autoimmunity, Werfen, San Diego, California (Wahl, Camacho, Aure, Mahler)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Mahler","sequence":"additional","affiliation":[{"name":"Research and Development, Headquarters and Technology Center Autoimmunity, Werfen, San Diego, California (Wahl, Camacho, Aure, Mahler)"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijayalakshmi","family":"Nandakumar","sequence":"additional","affiliation":[{"name":"From the ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, Utah (Novis, Nandakumar)"},{"name":"The Department of Pathology, University of Utah School of Medicine, Salt Lake City (Nandakumar)"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3906","published-online":{"date-parts":[[2023,3,1]]},"reference":[{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b01","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1136\/gutjnl-2011-301346","article-title":"The Oslo definitions for coeliac disease and related terms","volume":"62","author":"Ludvigsson","year":"2013","journal-title":"Gut"},{"issue":"(10344)","key":"2023112714485767100_i1543-2165-147-12-1422-b02","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","article-title":"Coeliac disease","volume":"399","author":"Catassi","year":"2022","journal-title":"Lancet"},{"issue":"(6)","key":"2023112714485767100_i1543-2165-147-12-1422-b03","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cgh.2017.06.037","article-title":"Global prevalence of celiac disease: systematic review and meta-analysis","volume":"16","author":"Singh","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b04","doi-asserted-by":"crossref","first-page":"507","DOI":"10.14309\/ajg.0000000000000523","article-title":"Incidence of celiac disease is increasing over time: a systematic review and meta-analysis","volume":"115","author":"King","year":"2020","journal-title":"Am J Gastroenterol"},{"issue":"(3)","key":"2023112714485767100_i1543-2165-147-12-1422-b05","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/apt.12373","article-title":"Systematic review: worldwide variation in the frequency of coeliac disease and changes over time","volume":"38","author":"Kang","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b06","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/ajg.2013.60","article-title":"Increasing incidence of celiac disease in a North American population","volume":"108","author":"Ludvigsson","year":"2013","journal-title":"Am J Gastroenterol"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b07","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1053\/j.gastro.2016.11.043","article-title":"Prevalence and morbidity of undiagnosed celiac disease from a community-based study","volume":"152","author":"Choung","year":"2017","journal-title":"Gastroenterology"},{"issue":"(6)","key":"2023112714485767100_i1543-2165-147-12-1422-b08","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1007\/s00431-021-03974-8","article-title":"Diagnosis of celiac disease is being missed in over 80% of children particularly in those from socioeconomically deprived backgrounds","volume":"180","author":"Whitburn","year":"2021","journal-title":"Eur J Pediatr"},{"issue":"(10115)","key":"2023112714485767100_i1543-2165-147-12-1422-b09","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/S0140-6736(17)31796-8","article-title":"Coeliac disease","volume":"391","author":"Lebwohl","year":"2018","journal-title":"Lancet"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b10","doi-asserted-by":"crossref","first-page":"355.e9","DOI":"10.1016\/j.amjmed.2005.08.044","article-title":"Trends in the presentation of celiac disease","volume":"119","author":"Rampertab","year":"2006","journal-title":"Am J Med"},{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/ajg.2008.8","article-title":"A report on the International Transglutaminase Autoantibody Workshop for Celiac Disease","volume":"104","author":"Li","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b12","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/MPG.0000000000002497","article-title":"European Society Paediatric Gastroenterology, Hepatology and Nutrition guidelines for diagnosing coeliac disease 2020","volume":"70","author":"Husby","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"(7)","key":"2023112714485767100_i1543-2165-147-12-1422-b13","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2036.2008.03609.x","article-title":"Coeliac disease: a biopsy is not always necessary for diagnosis","volume":"27","author":"Hill","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b14","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.dld.2011.10.013","article-title":"High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease","volume":"44","author":"Zanini","year":"2012","journal-title":"Dig Liver Dis"},{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b15","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1097\/MPG.0b013e3182470249","article-title":"Correlation between IgA tissue transglutaminase antibody ratio and histological finding in celiac disease","volume":"55","author":"Alessio","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"(6)","key":"2023112714485767100_i1543-2165-147-12-1422-b16","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1097\/MEG.0000000000000841","article-title":"Coeliac disease: further evidence that biopsy is not always necessary for diagnosis","volume":"29","author":"Holmes","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"(9)","key":"2023112714485767100_i1543-2165-147-12-1422-b17","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s10620-017-4672-1","article-title":"Application of the biopsy-sparing ESPGHAN guidelines for celiac disease diagnosis in adults: a real-life study","volume":"62","author":"Efthymakis","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b18","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MPG.0000000000001773","article-title":"Celiac disease diagnosis without biopsy: is a 10\u00d7 ULN antitransglutaminase result suitable for a chemiluminescence method?","volume":"66","author":"Previtali","year":"2018","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b19","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1136\/gutjnl-2020-320913","article-title":"Accuracy of a no-biopsy approach for the diagnosis of coeliac disease across different adult cohorts","volume":"70","author":"Penny","year":"2021","journal-title":"Gut"},{"issue":"(10)","key":"2023112714485767100_i1543-2165-147-12-1422-b20","doi-asserted-by":"crossref","first-page":"102641","DOI":"10.1016\/j.autrev.2020.102641","article-title":"Evaluation of novel assays for the detection of autoantibodies in antiphospholipid syndrome","volume":"19","author":"Sciascia","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b21","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3109\/00365529209000089","article-title":"Selective IgA deficiency and coeliac disease","volume":"27","author":"Collin","year":"1992","journal-title":"Scand J Gastroenterol"},{"volume-title":"R: A Language and Environment for Statistical Computing","year":"2019","author":"R Core Team","key":"2023112714485767100_i1543-2165-147-12-1422-b22"},{"issue":"(3)","key":"2023112714485767100_i1543-2165-147-12-1422-b23","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1053\/j.gastro.2020.05.016","article-title":"Association between inflammatory bowel diseases and celiac disease: a systematic review and meta-analysis","volume":"159","author":"Pinto-Sanchez","year":"2020","journal-title":"Gastroenterology"},{"issue":"(21-22)","key":"2023112714485767100_i1543-2165-147-12-1422-b24","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1016\/j.cca.2012.06.024","article-title":"Serological diagnosis of celiac disease: comparative analysis of different strategies","volume":"413","author":"Vermeersch","year":"2012","journal-title":"Clin Chim Acta"},{"issue":"(2)","key":"2023112714485767100_i1543-2165-147-12-1422-b25","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1365-2036.2010.04337.x","article-title":"Antibodies against deamidated gliadin peptides identify adult coeliac disease patients negative for antibodies against endomysium and tissue transglutaminase","volume":"32","author":"Dahle","year":"2010","journal-title":"Aliment Pharmacol Ther"},{"issue":"(11)","key":"2023112714485767100_i1543-2165-147-12-1422-b26","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cgh.2007.05.024","article-title":"Antibodies against synthetic deamidated gliadin peptides and tissue transglutaminase for the identification of childhood celiac disease","volume":"5","author":"Agardh","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b27","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1038\/ajg.2013.79","article-title":"ACG clinical guidelines: diagnosis and management of celiac disease","volume":"108","author":"Rubio-Tapia","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"2023112714485767100_i1543-2165-147-12-1422-b28","volume-title":"Diagnosis of Celiac Disease","author":"Maglione","year":"2016","edition":"162 ed"},{"issue":"(11)","key":"2023112714485767100_i1543-2165-147-12-1422-b29","first-page":"726","article-title":"Comparative accuracy of diagnostic tests for celiac disease","volume":"95","author":"Seehusen","year":"2017","journal-title":"Am Fam Physician"},{"key":"2023112714485767100_i1543-2165-147-12-1422-b30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cca.2019.02.002","article-title":"Deamidated gliadin peptide in pediatric patients with moderately increased tissue transglutaminase; does it help?","volume":"492","author":"Dickerson","year":"2019","journal-title":"Clin Chim Acta"},{"issue":"(4)","key":"2023112714485767100_i1543-2165-147-12-1422-b31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1053\/j.gastro.2017.06.002","article-title":"Accuracy in diagnosis of celiac disease without biopsies in clinical practice","volume":"153","author":"Werkstetter","year":"2017","journal-title":"Gastroenterology"},{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b32","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10620-016-4354-4","article-title":"Tissue transglutaminase levels are not sufficient to diagnose celiac disease in North American practices without intestinal biopsies","volume":"62","author":"Elitsur","year":"2017","journal-title":"Dig Dis Sci"},{"issue":"(1)","key":"2023112714485767100_i1543-2165-147-12-1422-b33","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1186\/s12913-020-05815-0","article-title":"Value of biopsy in a cohort of children with high-titer celiac serologies: observation of dynamic policy differences between Europe and North America","volume":"20","author":"Badizadegan","year":"2020","journal-title":"BMC Health Serv Res"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b34","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/ajg.2015.87","article-title":"Evaluation of the ESPGHAN celiac guidelines in a North American pediatric population","volume":"110","author":"Gidrewicz","year":"2015","journal-title":"Am J Gastroenterol"},{"issue":"(5)","key":"2023112714485767100_i1543-2165-147-12-1422-b35","doi-asserted-by":"crossref","first-page":"e97853","DOI":"10.1371\/journal.pone.0097853","article-title":"Antibodies in the diagnosis of coeliac disease: a biopsy-controlled, international, multicentre study of 376 children with coeliac disease and 695 controls","volume":"9","author":"Wolf","year":"2014","journal-title":"PLoS One"},{"key":"2023112714485767100_i1543-2165-147-12-1422-b36","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.cca.2022.05.008","article-title":"To DGP-IgG or not? A comparison of TTG-IgA and DGP-IgG","volume":"531","author":"Pacheco","year":"2022","journal-title":"Clin Chim Acta"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/12\/1422\/3293821\/i1543-2165-147-12-1422.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/meridian.allenpress.com\/aplm\/article-pdf\/147\/12\/1422\/3293821\/i1543-2165-147-12-1422.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:41:11Z","timestamp":1764790871000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/147\/12\/article-p1422.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":36,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,3,1]]},"published-print":{"date-parts":[[2023,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2022-0385-oa","relation":{},"ISSN":["1543-2165","0003-9985"],"issn-type":[{"type":"electronic","value":"1543-2165"},{"type":"print","value":"0003-9985"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}